<DOC>
	<DOC>NCT01225653</DOC>
	<brief_summary>Randomized double-blinded two-year intervention study with topical application of latanoprost or placebo eye drops in patients with diabetic retinopathy.</brief_summary>
	<brief_title>Topical Application of Latanoprost in Diabetic Retinopathy</brief_title>
	<detailed_description>The primary objective is to study if a sustained contraction of pathologically dilated retinal arterioles can be obtained. Retinal arteriolar diameter and the diameter response to increased blood pressure is studied using the Dynamic Vessel Analyzer (Imedos, Germany. The secondary objective is to study whether the intervention can halt the development of diabetic retinopathy, which is assessed by optical coherence tomography (OCT) scanning and fundus photography.</detailed_description>
	<mesh_term>Retinal Diseases</mesh_term>
	<mesh_term>Diabetic Retinopathy</mesh_term>
	<mesh_term>Latanoprost</mesh_term>
	<criteria>Age 2036 years old Diabetes mellitus with retinopathy Pregnancy Previous ocular disease other than diabetic retinopathy General disease with possible influence on the eye</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>36 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Latanoprost</keyword>
	<keyword>vasodilation</keyword>
	<keyword>diabetic retinopathy</keyword>
</DOC>